Skip to Main Content

Paper Details

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.
Cancer Res
209
2013
ATAD5, BRAF, ERBBs, NCI-60, NCI-60 cell lines, NCI-60 panel, TP53, bleomycin, cancer, cancer genes, cell lines, coding variants, erlotinib, exomes, genomic variants, human, human tumor cell lines, nutlin, tumor, vemurafenib
Antineoplastic Agents, Cell Line, Tumor, Drug Screening Assays, Antitumor, Exome, Genetic Variation, Humans, Mutation, Neoplasms, Pharmacogenetics
Author NameAffiliation
Ogan D AbaanCenter for Cancer Research, National Cancer Institute
Ogan D AbaanCenter for Cancer Research, National Cancer Institute
  • 1 - 2

Datasets

Release 1.2